Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial Of Raloxifene Plus Zoladex For Prevention Of Breast Cancer

NCT00031850 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT00031850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00031850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial Of Raloxifene Plus Zoladex For Prevention Of Breast Cancer
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2000
Completion date
May 31, 2007
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer